Are you Dr. Fenoglio-Preiser?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 29 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1661 E Camelback Rd
Ste 140
Phoenix, AZ 85016Phone+1 602-441-2000Fax+1 602-441-2034
Summary
- Dr. Cecilia Fenoglio-Preiser, MD is a board certified pathologist in Phoenix, Arizona. She is currently licensed to practice medicine in Arizona, Idaho, and North Dakota.
Education & Training
- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1974 - 1974
- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1970 - 1973
- New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1969 - 1969
- Georgetown University School of MedicineClass of 1969
Certifications & Licensure
- AZ State Medical License 2007 - Present
- CA State Medical License 2009 - Present
- NM State Medical License 1984 - 2021
- ID State Medical License 2013 - 2016
- ND State Medical License 2011 - 2016
- OH State Medical License 1990 - 2011
- American Board of Pathology Anatomic Pathology
Publications & Presentations
PubMed
- 17 citationsColorectal Chemoprevention Pilot Study (SWOG-9041), randomized and placebo controlled: the importance of multiple luminal lesions.David Chu, Michael A. Hussey, David S. Alberts, Frank L. Meyskens, Cecilia M. Fenoglio-Preiser
Clinical Colorectal Cancer. 2011-12-01 - 112 citationsSouthwest Oncology Group study S0413: a phase II trial of lapatinib (GW572016) as first-line therapy in patients with advanced or metastatic gastric cancer.Syma Iqbal, Bryan Goldman, Cecilia M. Fenoglio-Preiser, Heinz-Josef Lenz, Wu Zhang
Annals of Oncology. 2011-12-01 - 478 citationsPhase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergro...Philip A. Philip, Jacqueline Benedetti, Christopher L. Corless, Ralph Wong, Eileen M. O'Reilly
Journal of Clinical Oncology. 2010-08-01